LivaNova PLC Company Profile

13:14 EDT 21st September 2019 | BioPortfolio

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K. With a presence in more than 100 countries, LivaNova operates as three business franchises: Cardiac Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), respectively.

News Articles [39 Associated News Articles listed on BioPortfolio]

LivaNova wins approval from U.S. CMS for RECOVER clinical study

LivaNova, a market-leading medical technology and innovation company, today announced the U.S. Centers for Medicare & Medicaid Services (CMS) accepted the LivaNova protocol for ‘A Prospective, M...

LivaNova’s Perceval sutureless aortic heart valve receives national reimbursement in Japan

LivaNova said that the addition of Perceval into Japan’s health insurance system allows physicians and patients to have greater access to the biological heart valve. LivaNova Japan president The po...

LivaNova reports 6.7% sales growth in Q4

LivaNova reported a sales increase of 6.7% to $297 million in the fourth quarter versus the year before.  -More- 

LivaNova wins U.S. FDA 510(k) Clearance for LifeSPARC advanced circulatory support system

Derived from more than 20 years of life support experience with TandemLife, LifeSPARC begins a new chapter for ACS innovation within the LivaNova portfolio. Built around a common The post LivaNova wi...

CMS finalizes national coverage decision for LivaNova's VNS therapy

The CMS approved LivaNova's vagus nerve stimulation therapy for treatment-resistant depression for Medicare coverage through  -More- 

LivaNova to pay $225m to solve majority of cases with 3T Heater-Cooler device in US

LivaNova has entered into an agreement to settle around 75% of its previously disclosed litigation related to the 3T Heater-Cooler device, which includes three circuits for rapid and The post LivaNov...

CMS trial of LivaNova's VNS therapy to have sham-control arm

The CMS trial of LivaNova's Vagus Nerve Stimulation Therapy system for treatment-resistant depression will require a sham-con -More- 

FDA clears Livanova's Lifesparc circulatory support pump, controller

Livanova has obtained clearance from the FDA for its Lifesparc system, a smaller, versatile circulatory support pump and cont -More- 

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Outcome of a Modified Perceval Implantation Technique.

 In our institution, we developed a modification of the standard implantation technique of the Perceval sutureless aortic prosthesis (LivaNova, London, United Kingdom) that involves the usage of snu...

Right Anterior Minithoracotomy for Endocarditis Following Transcatheter Aortic Valve Replacement.

Transcatheter aortic valve replacement becomes an equivalent alternative to surgical aortic valve replacement also in low-surgical-risk patients. Prosthetic valve endocarditis following transcatheter ...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Behavior of Valve Leaflets

This is a prospective, interventional, multi-center trial to report the overall incidence of reduced leaflet motion identified by CT imaging in patients receiving a commercially approved L...

Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction

Age is no longer an absolute contraindication to cardiac surgery therefore there is often need for combined interventions (double valve repair/replacement, or coronary artery bypass graft ...

Companies [3 Associated Companies listed on BioPortfolio]

LivaNova, PLC

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Li...

LivaNova PLC

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical devic...


More Information about "LivaNova PLC" on BioPortfolio

We have published hundreds of LivaNova PLC news stories on BioPortfolio along with dozens of LivaNova PLC Clinical Trials and PubMed Articles about LivaNova PLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LivaNova PLC Companies in our database. You can also find out about relevant LivaNova PLC Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record